Upstage Lung Cancer Inc

Analysis

Upstage Lung Cancer Inc is a registered charity in United States, based in Brookline, MA. It received its IRS tax-exemption ruling in June 2009, 17 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Upstage Lung Cancer Inc reported income of $123k and spending of $136k, spending 111% of what it took in. Across the 2 years on record, from December 2022 to December 2023, income grew from $99k to $123k (+23%), an average of +23% a year. The sharpest change came in the year to December 2023, when income rose by 23%. Over the whole period it spent 117% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Upstage Lung Cancer Inc sits at the 31st percentile: it is larger than about 31% of them. Against every charity in United States with reported income it ranks in the 42nd percentile, and in the 48th percentile within MA. Charities of a similar size with the same main cause include Connect Thru Cancer ($123k), Maple Lane Benefit Stallion Presentation Inc ($123k) and Texas Society for Biomedical Research Inc ($123k).

On its Form 990-EZ for the period ending December 2023, revenue came from contributions and grants 95% of the total. At year end it held assets of $106k against liabilities of $0, net assets of $106k.